Literature DB >> 31747956

Value of muscle magnetic resonance imaging in the differential diagnosis of muscular dystrophies related to the dystrophin-glycoprotein complex.

Zhiying Xie1, Zhihao Xie2, Meng Yu1, Yiming Zheng1, Chengyue Sun1, Yilin Liu1, Chen Ling1, Ying Zhu3, Wei Zhang1, Jiangxi Xiao3, Zhaoxia Wang4, Yun Yuan5.   

Abstract

BACKGROUND: Dystrophin-glycoprotein complex (DGC)-related muscular dystrophies may present similar clinical and pathological features as well as undetectable mutations thus being sometimes difficult to distinguish. We investigated the value of muscle magnetic resonance imaging (MRI) in the differential diagnosis of DGC-related muscular dystrophies and reported the largest series of Chinese patients with sarcoglycanopathies studied by muscle MRI.
RESULTS: Fifty-five patients with DGC-related muscular dystrophies, including 22 with confirmed sarcoglycanopathies, 11 with limb-girdle muscular dystrophy 2I (LGMD2I, FKRP-associated dystroglycanopathy), and 22 with dystrophinopathies underwent extensive clinical evaluation, muscle biopsies, genetic analysis, and muscle MRI examinations. Hierarchical clustering of patients according to the clinical characteristics showed that patients did not cluster according to the genotypes. No statistically significant differences were observed between sarcoglycanopathies and LGMD2I in terms of thigh muscle involvement. The concentric fatty infiltration pattern was observed not only in different sarcoglycanopathies (14/22) but also in LGMD2I (9/11). The trefoil with single fruit sign was observed in most patients with dystrophinopathies (21/22), and a few patients with sarcoglycanopathies (4/22) or LGMD2I (2/11). Hierarchical clustering showed that most patients with sarcoglycanopathies or LGMD2I can be distinguished from dystrophinopathies based on the concentric fatty infiltration pattern and trefoil with single fruit sign at the thigh level on muscle MRI.
CONCLUSIONS: Muscle MRI at the thigh level potentially allows distinction of sarcoglycanopathies or FKRP-associated dystroglycanopathy from dystrophinopathies.

Entities:  

Keywords:  Differential diagnosis; Dystrophin-glycoprotein complex; Muscle magnetic resonance imaging; Muscular dystrophy

Year:  2019        PMID: 31747956     DOI: 10.1186/s13023-019-1242-y

Source DB:  PubMed          Journal:  Orphanet J Rare Dis        ISSN: 1750-1172            Impact factor:   4.123


  4 in total

1.  Duchenne muscular dystrophy-like phenotype in an LGMD2I patient with novel FKRP gene variants.

Authors:  Tetsuya Okazaki; Kaori Matsuura; Noriko Kasagi; Kaori Adachi; Masachika Kai; Mariko Okubo; Ichizo Nishino; Eiji Nanba; Yoshihiro Maegaki
Journal:  Hum Genome Var       Date:  2020-04-20

2.  First Identification of Rare Exonic and Deep Intronic Splice-Altering Variants in Patients With Beta-Sarcoglycanopathy.

Authors:  Zhiying Xie; Chengyue Sun; Chang Liu; Xujun Chu; Qiang Gang; Meng Yu; Yiming Zheng; Lingchao Meng; Fan Li; Dongliang Xia; Li Wang; Ying Li; Jianwen Deng; He Lv; Zhaoxia Wang; Wei Zhang; Yun Yuan
Journal:  Front Pediatr       Date:  2022-06-22       Impact factor: 3.569

3.  Duchenne muscular dystrophy-like phenotype in an LGMD2I patient with novel FKRP gene variants.

Authors:  Tetsuya Okazaki; Kaori Matsuura; Noriko Kasagi; Kaori Adachi; Masachika Kai; Mariko Okubo; Ichizo Nishino; Eiji Nanba; Yoshihiro Maegaki
Journal:  Hum Genome Var       Date:  2020-04-20

4.  Long-read whole-genome sequencing for the genetic diagnosis of dystrophinopathies.

Authors:  Zhiying Xie; Chengyue Sun; Siwen Zhang; Yilin Liu; Meng Yu; Yiming Zheng; Lingchao Meng; Anushree Acharya; Diana M Cornejo-Sanchez; Gao Wang; Wei Zhang; Isabelle Schrauwen; Suzanne M Leal; Zhaoxia Wang; Yun Yuan
Journal:  Ann Clin Transl Neurol       Date:  2020-09-20       Impact factor: 4.511

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.